Latest Breaking News On - Department of neuroimmunology - Page 1 : vimarsana.com

Immune System Reboot in MS Patients

Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study led by the University of Zurich has now exam..

Roland martinDepartment of medical oncologyUniversity hospital zurichDepartment of neuroimmunologyMartin departmentMs researchUniversity of zurichMedical oncologyHaematology clinicProfessor roland martin

Research reveals why stem cell transplants are so successful in MS patients

Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study led by the University of Zurich has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterwards.

Roland martinEmily hendersonDepartment of medical oncologyUniversity hospital zurichDepartment of neuroimmunologyMartin departmentOffice of public healthMs researchUniversity of zurichMedical oncologyHaematology clinicProfessor roland martinFederal officePublic healthImmune systemAutoimmune disease

AstraZeneca Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis

Ultomiris (ravulizumab), the first and only long-acting C5 complement inhibitor, offers immediate, complete and sustained complement inhibition.

Istituto neurologico carlo bestaMarc dunoyerRenato mantegazzaCommittee for medicinal products humanDepartment of neuroimmunologyEuropean commissionMedicinal productsHuman useMyasthenia gravis activitiesDaily living profileNeuromuscular diseasesNeurologico carlo bestaChief executive officerAstrazeneca newsGeneralised myasthenia gravisNejm evidence

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Ultomiris approved in EU for gMG

Investegate announcements from AstraZeneca PLC, Ultomiris approved in EU for gMG

United statesUnited kingdomRepublic of irelandIstituto neurologico carlo bestaMarc dunoyerAdrian kempRenato mantegazzaNational organization for rare disordersDepartment of neuroimmunologyEuropean commissionAlexion pharmaceuticals incCommittee for medicinal products humanInvestor relations teamNational institutes of neurological disordersYork academy of sciencesMedicinal products

Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis

Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomIstituto neurologico carlo bestaMarc dunoyerRenato mantegazzaCompany on twitter astrazenecaCommittee for medicinal products humanDepartment of neuroimmunologyEuropean commissionAlexion pharmaceuticals incMedicinal productsHuman useMyasthenia gravis activitiesDaily living profileNeuromuscular diseasesNeurologico carlo besta